Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Patient Enrollment Completed in Phase III Clinical Study of Adapalene-Clindamycin Combination Gel in China 2019-11-22 23:50
Thrombosis Research Institute (TRI) Launches Innovative Risk Calculator for Predicting Stroke, Major Bleeding and Mortality in Atrial Fibrillation Over Two Years 2019-11-21 23:05
Ascentage Pharma Breaks Ground on its Global Headquarters, R&D Center and Manufacturing Facility in the Suzhou Industrial Park 2019-11-21 11:30
NeuroVive Pharmaceutical AB Interim Report January - September 2019 2019-11-20 16:38
Cambridge Quantum Computing Achieves Groundbreaking Results in Quantum Chemistry 2019-11-20 15:00
Merck Announces Orphan Drug Designation for Investigational Therapy Tepotinib in Patients with NSCLC Harboring MET Gene Alterations 2019-11-20 15:00
CStone announces first patient dosed in the Phase I bridging registrational study of ivosidenib 2019-11-20 11:41
Excelra Announces a Drug Repurposing Collaboration With Maruho On Dermatological Applications 2019-11-20 10:00
3SBio Selects Verseau's PSGL-1-targeted Antibody VTX-0811 as First Partnered Macrophage Checkpoint Modulator in Immuno-Oncology Collaboration 2019-11-18 08:30
BioDuro chooses SciFinder-n from CAS to enhance research productivity and shorten cycle times for client success 2019-11-18 08:15
Unprecedented Gathering of Asia Pacific Medical Societies to Respond to the Impact of Antibiotic Resistance on All People 2019-11-17 12:00
Viva Biotech Partnership Summit Successfully Launched in Shanghai 2019-11-15 14:16
I-Mab Biopharma Receives IND Approval from NMPA to Initiate Clinical Trials for its Anti-GM-CSF Monoclonal Antibody TJM2 in China 2019-11-14 23:45
Samsung Biologics Enhances Its Trusted Service as the First and Only ISO27001 Certified CDMO 2019-11-14 20:00
MeMed Wins €2.5M Award from European Innovation Council 2019-11-14 09:00
China Biologic Reports Financial Results for the Third Quarter of 2019 2019-11-14 05:43
Merck Licenses CRISPR Gene-Editing Technology to Evotec 2019-11-12 21:00
ATAI Life Sciences and Cyclica launch joint venture to revolutionize drug development for mental health disorders 2019-11-11 21:45
Akesobio Presents Phase 1 Clinical Data from First-in-class Bispecific Drug Candidate AK104 (PD1/CTLA4) As Oral Presentation, at 2019 SITC Annual Meeting 2019-11-11 17:35
Akeso, Inc. Completes Series-D Private Financing for US$150 Million 2019-11-09 00:43
1 323 324 325 326 327 423